Stem cells try the intranasal route; Salmonella prepped as delivery agent;

> Intranasal delivery of stem cells to the brains of rats with Parkinson disease yielded  motor function improvement and a reversal of dopamine deficiency. Item

> UC Berkeley researchers have made a modified strain of Salmonella to deliver interfering RNA exactly where needed. Article

> The consultancy Technology Catalysts finds upside potential in parenteral depots via reformulation of marketed drugs, use as  an alternative pathway in drug development, and use as a competitive differentiator for biosimilars. Release

> Bioject Medical will supply its Intradermal Pen disposable-syringe jet injector, still under development, to WHO for clinical research of intradermal delivery of vaccines in developing-country immunization programs.

> Dispensers cut in half the likelihood of dosing mistakes with pills and capsules compared with non-dispenser administration in homes for the elderly. Article

> Alvogen has launched a nitroglycerin transdermal system boasting small patch sizes and RSS bar coding. Release

> Some drugmakers are giving needle-free injection technology a second look, thanks to improved device designs, patient sentiment, and new therapeutic applications. Release

And Finally... Elan Drug Technologies won the Pipeline Value Creation Award at the Drug Delivery Partnerships meeting last month; Zogenix won the Innovation Award. Release | Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.